Sign In
CPSI Share                                                                      
​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​ ​​
Publication Type: Safety Notice
Single or Multiple Incident: Multiple
Date: 9/10/2021 12:00:00 AM
Country: Australia

This safety notice highlights the potential medication incidents which could occur with new labelling of concentrated potassium chloride by Pfizer. The previous labelling of 10 mmol (0.75 g) in 10 mL Sterile Potassium Chloride Concentrate has been changed to 75 mg in 1 mL. Healthcare professionals typically prescribe and dispense potassium chloride using millimoles (mmol). While Pfizer will be revising the labelling to use the mmol designation, interim measures are required for this product. The notice provides details to be implemented to reduce the risk of medication errors.

Additional Details

potassium chloride concnetrate injectable
Medication/IV List:
potassium chloride for injection concentrate

Safety risks due to new labelling on the outer carton packaging of intravenous potassium chloride ampoules